Biotechnology stocks are on track to beat the stock market for a remarkable fifth year straight. The largest biotech exchange-traded fund, iShares Nasdaq Biotechnology ETF (IBB), with more than $9 billion in assets, rallied an average of 36% the past five years vs. 10.4% for the SPDR S&P 500 ETF (SPY). On a 10-year basis, IBB earned investors a 17% return annually vs. 6% for SPY, according to Morningstar.
Hey, check out all the research scientist jobs. Post your resume today!
